Kowa Co., Ltd. engages in trading of textiles, machinery, and construction materials. The company also manufactures and sells medicines, medical equipment, and energy saving products. It operates through the following business divisions: Pharmaceutical, Medical Device, Foods, General Trading, Lifestyle Business, and Hospitality. The company was founded on December 25, 1894 and is headquartered in Nagoya, Japan.

3M Innovative Properties Co. acquires and manages intellectual property right. It engages in the acquisition and ownership of the intellectual property rights to the products designed and manufactured by its parent company 3M Corporation. The company was founded on May 10, 1999 and is headquartered in Roseville, MN.

Kindeva Drug Delivery LP engages in the pharmaceutical contract development and manufacturing. It is also involved in the formulation, product development, scale up manufacturing, and commercial manufacturing. The company was founded by William Riker in 1846 and is headquartered in St. Paul, MN.

Biolab is one of the 10 largest pharmaceutical companies in Brazil. The main characteristics about the trajectory is based on the commitment to offer health and quality of life to the Brazilian population. It is a market leader in Cardiology medicine prescriptions, vice-leader in the segment of Gynecology and acts with relevance in the areas of Dermatology, Orthopedics, Rheumatology and Pediatrics.

Orexa is a pharmaceutical company that provides therapeutics to increase food intake. Its main ingredient is a human-use oral formulation that is proprietary and based on a well-known anesthetic. The company's invention is based on several well-known anesthetics with a well-established safety profile. These anesthetics are typically administered by injection, but Orexa's research demonstrates that they can also be administered orally with a local mode of action.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Sintetica is a Swiss pharmaceutical company specialized in the research, manufacturing and marketing of sterile injectable solutions, including anaesthetic, analgesic and adrenergic drugs, distributed in more than 45 countries.

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Chemeq Ltd. develops, manufactures and markets polymeric antimicrobials drugs for the control of disease causing bacteria in commercial animal production. It is focused on its CHEMEQ® polymeric antimicrobial for the prevention and control of intestinal bacterial diseases in feedstock animals such as pigs and poultry. The company was founded in 1985 and is headquartered in Rockingham, Australia.

Part of Catalent, Inc., Columbia Laboratories (Bermuda) Ltd. is a Bermudian company located in Hamilton. The firm manufactures pharmaceutical products.

Beijing Zhongtaibang Pharmaceutical Technology Co., Ltd., established on 2019-03-21, Business scope includes technology development,technical consulting,technology transfer,Technology Promotion,Technical Services;Sales of Class I Medical Devices,Electrical Equipment,Equipment,Chemical Products(Non-pharmaceutical precursor chemicals in the first category are excluded),household appliances,electronic product;Organize cultural and artistic exchange activities;software development;Information system integration service;data processing;market survey;Business Management Consulting,business inquiries;Undertake the exhibition;Conference Services;Medical Research and Experimental Development;translation service;packaging service;Sell ​​self-developed products;pharmaceutical production.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Pharmaceutical production and projects subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Huzhou Enovix Pharmaceutical Co., Ltd., established on 2016-07-19, Business scope includes technical research and development of biopharmaceutical preparations,technology transfer,Technical Consulting and Technical Services.

Hind Health Care, Inc. is an American private company specializing in home health care services.